@article{67f769b551c14a5698731d7605db0179,
title = "The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease",
keywords = "Alzheimer's disease, Glucagon-like peptide-1, Hippocampus, Inflammation, Insulin receptor, Insulin receptor substrate-1, Insulin signaling, Liraglutide, Streptozotocin, Type 3 diabetes",
author = "Konrad Talbot and Wang, {Hoau Yan}",
note = "Funding Information: This work was supported by grants from the National Institute on Aging ( R01 AG15819 , P30 AG10124 , and P30 AG10161 ) and from the Alzheimer's Association . The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials addressed in this article. ",
year = "2014",
doi = "10.1016/j.jalz.2013.12.007",
language = "English",
volume = "10",
pages = "S12--S25",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
number = "1 SUPPL.",
}